Bank Of New York Mellon Corp Personalis, Inc. Transaction History

Bank Of New York Mellon Corp

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.78 - $3.64 $26,698 - $54,596	14,999 New	14,999 $29,000
Q3 2022 Nov 14, 2022	SELL	$2.89 - $5.32 $13,640 - $25,110	-4,720 Reduced 21.23%	17,513 $52,000
Q2 2022 Aug 15, 2022	SELL	$3.27 - $8.76 $333,170 - $892,530	-101,887 Reduced 82.09%	22,233 $77,000
Q1 2022 May 11, 2022	BUY	$7.56 - $14.3 $13,146 - $24,867	1,739 Added 1.42%	124,120 $1.02 Million
Q4 2021 Feb 11, 2022	SELL	$12.24 - $21.25 $31,591 - $54,846	-2,581 Reduced 2.07%	122,381 $1.75 Million
Q3 2021 Nov 12, 2021	BUY	$16.69 - $26.05 $269,944 - $421,332	16,174 Added 14.87%	124,962 $2.4 Million
Q2 2021 Aug 11, 2021	BUY	$18.15 - $27.75 $333,125 - $509,323	18,354 Added 20.3%	108,788 $2.75 Million
Q1 2021 May 13, 2021	BUY	$20.71 - $51.02 $58,153 - $143,264	2,808 Added 3.2%	90,434 $2.23 Million
Q4 2020 Feb 09, 2021	BUY	$21.84 - $44.0 $418,541 - $843,216	19,164 Added 27.99%	87,626 $3.21 Million
Q3 2020 Nov 12, 2020	BUY	$13.63 - $24.12 $264,094 - $467,349	19,376 Added 39.47%	68,462 $1.48 Million
Q2 2020 Aug 12, 2020	SELL	$7.65 - $14.11 $8,828 - $16,282	-1,154 Reduced 2.3%	49,086 $636,000
Q1 2020 May 06, 2020	BUY	$4.75 - $12.41 $112,465 - $293,831	23,677 Added 89.14%	50,240 $405,000
Q4 2019 Feb 14, 2020	SELL	$8.73 - $12.95 $196,276 - $291,154	-22,483 Reduced 45.84%	26,563 $289,000
Q3 2019 Nov 07, 2019	BUY	$14.16 - $25.34 $165,700 - $296,528	11,702 Added 31.34%	49,046 $719,000
Q2 2019 Aug 12, 2019	BUY	$27.0 - $30.25 $1.01 Million - $1.13 Million	37,344 New	37,344 $1.01 Million

109

30.9M

16.9K

90.8K

Ticker PSNL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 45,918,400
Market Cap $253M
Description
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.